文献速递中医骨伤中医康复针灸推拿

中医三联康复疗法治疗膝骨关节炎:696例门诊患者多中心随机对照试验

Chinese Medicine Involving Triple Rehabilitation Therapy for Knee Osteoarthritis in 696 Outpatients: A Multi-Center, Randomized Controlled Trial.
PubMed 文献 · Chin J Integr Med · 2021-03-12

该多中心整群随机对照试验纳入722例膝骨关节炎患者,比较中医三联康复疗法(电针、中药熏洗、传统锻炼)联合健康教育与常规康复疗法的效果。696例完成全程,治疗组在Lequesne指数、VAS评分、下肢肌力、膝关节周长、症状量化评分及SF-36评分方面均优于对照组(P<0.05或P<0.01),未见不良反应,适合早中期患者。

要点

  • 中医三联康复疗法可减轻膝骨关节炎疼痛肿胀、改善下肢肌力与膝关节活动。
  • 该疗法在Lequesne指数、VAS、SF-36等多指标上优于常规康复疗法。
  • 研究期间未观察到不良反应,适用于早中期膝骨关节炎患者。

核心结论

  • 中医三联康复疗法可缓解膝骨关节炎相关疼痛与肿胀,改善下肢肌力,促进膝关节屈曲与活动,并提高患者生活质量。
  • 该疗法适合早中期膝骨关节炎患者。

研究设计与样本

  • 多中心整群随机对照试验,2013年3月至2017年3月从中国38家社区卫生服务中心招募722例患者,等量随机分为治疗组与对照组。
  • 696例完成全程,治疗组351例,对照组345例。

主要发现

  • 在所有治疗观察点,治疗组在Lequesne指数总分、总分有效率与改善率、VAS评分、下肢肌力、膝关节周长、KOA症状量化评分及SF-36评分方面均优于对照组(P<0.05或P<0.01)。
  • 本研究未遇到不良反应。

关键数值与推荐

  • 治疗组接受健康教育联合中医三联康复疗法(电针、中药熏洗、传统锻炼);对照组接受常规康复疗法(物理因子治疗、关节活动训练、肌力训练)。
  • VAS评分≽4的患者使用分散片美洛昔康(7.5 mg,每日一次)。
  • 在治疗前、4周治疗期内第2周和第4周、治疗结束后1个月和3个月共5个检查点测量Lequesne指数评分、VAS评分、关节活动度、下肢肌力、膝关节周长、KOA症状量化评分及SF-36评分。

临床怎么用

  • 对早中期膝骨关节炎门诊患者,可在健康教育基础上联合电针、中药熏洗和传统锻炼的三联康复方案。
  • 治疗期间VAS评分≽4者可配合美洛昔康7.5 mg每日一次口服。
  • 采用Lequesne指数、VAS、下肢肌力、膝关节周长及SF-36等指标在治疗前、治疗第2周和第4周、治疗后1个月和3个月进行疗效评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine the effects of Chinese medicine (CM) involving triple rehabilitation therapy on the progression of knee osteoarthritis (KOA). METHODS: A total of 722 patients recruited from 38 community health service centers located in China from March 2013 to March 2017 were randomly divided into treatment and control groups equally, using a cluster randomization design. Health education combined with CM involving triple rehabilitation therapy for KOA (electro-acupuncture, Chinese medicinal herb fumigating-washing, and traditional exercises) was administered in the treatment group while conventional rehabilitation therapy (physical factor therapy, joint movement training, and muscle strength training) was administered in the control group. Patients with a visual analog scale (VAS) scores ≽4 were treated with dispersible meloxicam tablets (7.5 mg, once daily). The Lequesne index scores, VAS scores, range of motion (ROM), lower limb muscle strength, knee joint circumference, quantitative scores of KOA symptoms, and the short-form 36 item health survey questionnaire (SF-36) scores were measured for each patient at 5 checkpoints (before treatment, at the 2nd week and the 4th week during the 4-week treatment period, at 1 month and 3 months after end of treatment), and adverse reactions were observed also. RESULTS: A total of 696 patients completed the entire process, with 351 in the treatment group and 345 in the control group. At all treatment checkpoints, the treatment group demonstrated better outcomes than the control group with regard to the total Lequesne index scores, effective rate and improvement rate of the total Lequesne index scores, VAS scores, lower limb muscle strength, knee circumference, quantitative scores of KOA symptoms, and SF-36 scores as well (P<0.05 or P<0.01). No adverse reactions were encountered in this study. CONCLUSIONS: CM involving triple rehabilitation therapy can alleviate KOA-related pain and swelling, improve lower limb muscle strength, promote flexion and activity of the knee and improve the quality of life in patients undergoing KOA. It is suitable for patients with early or mid-stage KOA. (Registration No. ChiCTR-TRC-12002538).

来源:Chin J Integr Med,查看原文。版权归原作者所有。

引用

  1. Guo JM, Xiao Y, Cai TY, et al. Chinese Medicine Involving Triple Rehabilitation Therapy for Knee Osteoarthritis in 696 Outpatients: A Multi-Center, Randomized Controlled Trial. Chin J Integr Med. 2021. PMID: 33709238. doi:10.1007/s11655-021-3488-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。